Neuromuscular disease models and analysis

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 347-393

  Burgess, Robert W ^a   Cox, Gregory A ^a   Seburn, Kevin L ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

amyotrophic lateral sclerosis (ALS); Charcot Marie Tooth diseases; congenital myasthenic syndromes; Duchenne's disease; hereditary motor and or sensory neuropathies (HSMNs); Motor neuron diseases; muscular dystrophies; neuromuscular junction; peripheral neuropathies; spinal muscular atrophy (SMA)

Indexed keywords

ANIMALIA; MUS;

ANIMAL; ARTICLE; CYTOLOGY; DISEASE MODEL; ELECTROPHYSIOLOGY; EXERCISE TEST; GAIT; HISTOLOGY; HUMAN; INSTRUMENTATION; METHODOLOGY; MOTONEURON; MOUSE; MOUSE STRAIN; MUSCLE CONTRACTION; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHENOTYPE; PHYSIOLOGY; SPINAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; EXERCISE TEST; GAIT; HUMANS; MICE; MICE, INBRED STRAINS; MOTOR NEURONS; MUSCLE CONTRACTION; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; SPINAL CORD;

EID: 77449125821     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_20     Document Type: Article

References (171)

1. Hegedus, J., Putman, C. T. and Gordon, T. (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28, 154-164. (Pubitemid 47615455)
2. Grohmann, K., Schuelke, M., Diers, A., Hoffmann, K., Lucke, B., Adams, C., et al. (2001) Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 29, 75-77. (Pubitemid 32801813)
3. Seburn, K. L., Nangle, L. A., Cox, G. A., Schimmel, P. and Burgess, R. W. (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51, 715-726. (Pubitemid 44374911)
4. Court, F. A., Sherman, D. L., Pratt, T., Garry, E. M., Ribchester, R. R., Cottrell, D. F., et al. (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431, 191-195. (Pubitemid 39243472)
5. Son, Y. J. and Thompson,W. J. (1995) Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron 14, 133-141.
6. Son, Y. J. and Thompson, W. J. (1995) Schwann cell processes guide regeneration of peripheral axons. Neuron 14, 125-132.
7. Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R. O., Snider, W. D., Johnson, E. M., Jr., et al. (1998) GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21, 317-324. (Pubitemid 28399692)
8. Patton, B. L., Cunningham, J. M., Thyboll, J., Kortesmaa, J., Westerblad, H., Edstrom, L., et al. (2001) Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci 4, 597-604. (Pubitemid 32507373)
9. Pun, S., Santos, A. F., Saxena, S., Xu, L. and Caroni, P. (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9, 408-419. (Pubitemid 43290971)
10. Morgan, D., Munireddy, S., Alamed, J., Deleon, J., Diamond, D. M., Bickford, P., et al. (2008) Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice. J Alzheimers Dis 15, 605-614.
11. Stam, N. C., Nithianantharajah, J., Howard, M. L., Atkin, J. D., Cheema, S. S. and Hannan, A. J. (2008) Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 28, 717-723.
12. Turgeman, T., Hagai, Y., Huebner, K., Jassal, D. S., Anderson, J. E., Genin, O., et al. (2008) Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone. Neuromuscul Disord 18, 857-868.
13. Bohlen, M., Cameron, A., Metten, P., Crabbe, J. C. and Wahlsten, D. (2009) Calibration of rotational acceleration for the rotarod test of rodent motor coordination. J Neurosci Methods 178, 10-14.
14. Rustay, N. R., Wahlsten, D. and Crabbe, J. C. (2003) Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 141, 237-249. (Pubitemid 36542972)
15. Bautmans, I. and Mets, T. (2005) A fatigue resistance test for elderly persons based on grip strength: reliability and comparison with healthy young subjects. Aging Clin Exp Res 17, 217-222. (Pubitemid 41558107)
16. Fernagut, P. O., Diguet, E., Labattu, B. and Tison, F. (2002) A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods 113, 123-130. (Pubitemid 34076535)
17. Wooley, C. M., Sher, R. B., Kale, A., Frankel, W. N., Cox, G. A. and Seburn, K. L. (2005) Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32, 43-50. (Pubitemid 40917888)
18. Wooley, C. M., Xing, S., Burgess, R. W., Cox, G. A. and Seburn, K. L. (2009) Age, experience and genetic background influence treadmill walking in mice. Physiol Behav 96, 350-361.
19. Brooks, S. V., Faulkner, J. A. and McCubbrey, D. A. (1990) Power outputs of slow and fast skeletal muscles of mice. J Appl Physiol 68, 1282-1285. (Pubitemid 20136463)
20. Seburn, K. L. and Gardiner, P. (1995) Adaptations of rat lateral gastrocnemius motor units in response to voluntary running. J Appl Physiol 78, 1673-1678.
21. Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., Brooks, S. V. and Faulkner, J. A. (2001) Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 535, 591-600. (Pubitemid 32825693)
22. Brooks, S. V. and Faulkner, J. A. (1988) Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404, 71-82.
23. Grange, R. W., Gainer, T. G., Marschner, K. M., Talmadge, R. J. and Stull, J. T. (2002) Fast-twitch skeletal muscles of dys trophic mouse pups are resistant to injury from acute mechanical stress. Am J Physiol Cell Physiol 283, C1090-1101.
24. Belluardo, N., Westerblad, H., Mudo, G., Casabona, A., Bruton, J., Caniglia, G., et al. (2001) Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci 18, 56-67. (Pubitemid 32695192)
25. Danieli-Betto, D., Esposito, A., Germinario, E., Sandona, D., Martinello, T., Jakubiec-Puka, A., et al. (2005) Deficiency of alpha-sarcoglycan differently affects fastand slow-twitch skeletal muscles. Am J Physiol Regul Integr Comp Physiol 289, R1328-1337. (Pubitemid 41507397)
26. Grange, R. W., Meeson, A., Chin, E., Lau, K. S., Stull, J. T., Shelton, J. M., et al. (2001) Functional and molecular adaptations in skeletal muscle of myoglobinmutant mice. Am J Physiol Cell Physiol 281, C1487-1494.
27. Parry, D. J. and Desypris, G. (1985) Fatiguability and oxidative capacity of forelimb and hind limb muscles of dystrophic mice. Exp Neurol 87, 358-368. (Pubitemid 15174409)
28. Swallow, J. G., Garland, T., Jr., Carter, P. A., Zhan, W. Z. and Sieck, G. C. (1998) Effects of voluntary activity and genetic selection on aerobic capacity in house mice (Mus domesticus). J Appl Physiol 84, 69-76. (Pubitemid 28065112)
29. Shefner, J. M. (2001) Motor unit number estimation in human neurological diseases and animal models. Clin Neurophysiol 112, 955-964. (Pubitemid 32497238)
30. McComas, A. J., Fawcett, P. R., Campbell, M. J. and Sica, R. E. (1971) Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry 34, 121-131.
31. Major, L. A., Hegedus, J., Weber, D. J., Gordon, T. and Jones, K. E. (2007) Method for counting motor units in mice and validation using a mathematical model. J Neurophysiol 97, 1846-1856. (Pubitemid 46239551)
32. Ebels, E. J. (1975) Dark neurons: a significant artifact: the influence of the maturational state of neurons on the occurrence of the phenomenon. Acta Neuropathol 33, 271-273.
33. Garman, R. H. (1990) Artifacts in routinely immersion fixed nervous tissue. Toxicol Pathol 18, 149-153. (Pubitemid 20198803)
34. Jortner, B. S. (2006) The return of the dark neuron. A histological artifact complicating contemporary neurotoxicologic evaluation. Neurotoxicology 27, 628-634. (Pubitemid 43870381)
35. Schr̀eoder, J. M. (2001) Pathology of peripheral nerves: an atlas of structural and molecular pathological changes, Springer, Berlin/New York.
36. Emery, A. E. H. (1998) Neuromuscular disorders: clinical and molecular genetics, John Wiley, Chichester/New York.
37. Dyck, P. J. and Thomas, P. K. (2005) Peripheral neuropathy, 4th ed. Elsevier Saunders, Philadelphia, PA.
38. Engel, A. and Franzini-Armstrong, C. (2004) Myology: basic and clinical, 3rd ed. McGraw-Hill, Medical Pub. Division, INTbreak; New York.
39. Maddatu, T. P., Garvey, S. M., Schroeder, D. G., Hampton, T. G. and Cox, G. A. (2004) Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. Hum Mol Genet 13, 1105-1115. (Pubitemid 38786993)
40. Hershkovitz, E., Rozin, I., Limony, Y., Golan, H., Hadad, N., Gorodischer, R., et al. (2007) Hypoparathyroidism, retardation, and dysmorphism syndrome: impaired early growth and increased susceptibility to severe infections due to hyposplenism and impaired polymorphonuclear cell functions. Pediatr Res 62, 505-509. (Pubitemid 47476214)
41. Noakes, P. G., Miner, J. H., Gautam, M., Cunningham, J. M., Sanes, J. R. and Merlie, J. P. (1995) The renal glomerulus of mice lacking s-laminin/laminin b2: nephrosis despite molecular compensation by laminin b1. Nat Genet 10, 400-406.
42. Zhai, R. G., Cao, Y., Hiesinger, P. R., Zhou, Y., Mehta, S. Q., Schulze, K. L., et al. (2006) Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol 4, e416.
43. Zhai, R. G., Zhang, F., Hiesinger, P. R., Cao, Y., Haueter, C. M. and Bellen, H. J. (2008) NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration. Nature 452, 887-891. (Pubitemid 351550857)
44. Press, C. and Milbrandt, J. (2008) Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J Neurosci 28, 4861-4871.
45. Maddatu, T. P., Garvey, S. M., Schroeder, D. G., Zhang, W., Kim, S. Y., et al. (2005) Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival. Hum Mol Genet 14, 3179-3189. (Pubitemid 41631293)
46. Grohmann, K., Schuelke, M., Diers, A., Hoffmann, K., Lucke, B., Adams, C., et al. (2001) Mutations in the gene encoding immunoglobulin-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 29, 75-77.
47. Cox, G. A., Mahaffey, C. L. and Frankel, W. N. (1998) Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 21, 1327-1337. (Pubitemid 29022535)
48. Monani, U. R., Pastore, M. T., Gavrilina, T. O., Jablonka, S., Le, T. T., Andreassi, C., et al. (2003) A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol 160, 41-52. (Pubitemid 36091715)
49. Le, T. T., Pham, L. T., Butchbach, M. E., Zhang, H. L., Monani, U. R., Coovert, D. D., et al. (2005) SMN Delta 7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14, 845-857. (Pubitemid 40403280)
50. Monani, U. R., Sendtner, M., Coovert, D. D., Parsons, D. W., Andreassi, C., Le, T. T., et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9, 333-339. (Pubitemid 30098725)
51. Schrank, B., Gotz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., et al. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 94, 9920-9925. (Pubitemid 27408166)
52. Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M., et al. (2002) A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat Genet 32, 443-447. (Pubitemid 35266123)
53. Bommel, H., Xie, G., Rossoll, W., Wiese, S., Jablonka, S., Boehm, T., et al. (2002) Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J Cell Biol 159, 563-569.
54. Puls, I., Jonnakuty, C., LaMonte, B. H., Holzbaur, E. L., Tokito, M., Mann, E., et al. (2003) Mutant dynactin in motor neuron disease. Nat Genet 33, 455-456. (Pubitemid 36390002)
55. Chevalier-Larsen, E. S., Wallace, K. E., Pennise, C. R. and Holzbaur, E. L. (2008) Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin. Hum Mol Genet 17, 1946-1955. (Pubitemid 351865843)
56. Lai, C., Lin, X., Chandran, J., Shim, H., Yang, W. J. and Cai, H. (2007) The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J Neurosci 27, 13982-13990. (Pubitemid 351377874)
57. LaMonte, B. H., Wallace, K. E., Holloway, B. A., Shelly, S. S., Ascano, J., Tokito, M., et al. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715-727. (Pubitemid 34628735)
58. Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H. and Gordon, J. W. (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92, 689-693.
59. Kunst, C. B., Messer, L., Gordon, J., Haines, J. and Patterson, D. (2000) Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 70, 181-189. (Pubitemid 32003395)
60. Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338. (Pubitemid 27111114)
61. Wang, J., Xu, G., Gonzales, V., Coonfield, M., Fromholt, D., Copeland, N. G., et al. (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis 10, 128-138. (Pubitemid 34775466)
62. Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
63. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. (Pubitemid 24227760)
64. Heiman-Patterson, T. D., Deitch, J. S., Blankenhorn, E. P., Erwin, K. L., Perreault, M. J., Alexander, B. K., et al. (2005) Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci 236, 1-7. (Pubitemid 41218685)
65. Messer, A. and Flaherty, L. (1986) Autosomal dominance in a late-onset motor neuron disease in the mouse. J Neurogenet 3, 345-355. (Pubitemid 17186032)
66. Bronson, R. T., Lake, B. D., Cook, S., Taylor, S. and Davisson, M. T. (1993) Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann Neurol 33, 381-385. (Pubitemid 23103970)
67. Ranta, S., Zhang, Y., Ross, B., Lonka, L., Takkunen, E., Messer, A., et al. (1999) The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23, 233-236. (Pubitemid 29455400)
68. Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., et al. (2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808-812. (Pubitemid 36532118)
69. Chen, X. J., Levedakou, E. N., Millen, K. J., Wollmann, R. L., Soliven, B. and Popko, B. (2007) Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J Neurosci 27, 14515-14524.
70. Ilieva, H. S., Yamanaka, K., Malkmus, S., Kakinohana, O., Yaksh, T., Marsala,M., et al. (2008) Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci USA 105, 12599-12604.
71. Chow, C. Y., Landers, J. E., Bergren, S. K., Sapp, P. C., Grant, A. E., Jones, J. M., et al. (2009) Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 84, 85-88.
72. Chow, C. Y., Zhang, Y., Dowling, J. J., Jin, N., Adamska, M., Shiga, K., et al. (2007) Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448, 68-72. (Pubitemid 47036999)
73. Zhang, X., Chow, C. Y., Sahenk, Z., Shy, M. E., Meisler, M. H. and Li, J. (2008) Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 131, 1990-2001.
74. Schmitt-John, T., Drepper, C., Mussmann, A., Hahn, P., Kuhlmann, M., Thiel, C., et al. (2005) Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat Genet 37, 1213-1215. (Pubitemid 41568703)
75. Suter, U., Welcher, A. A., Ozcelik, T., Snipes, G. J., Kosaras, B., Francke, U., et al. (1992) Trembler mouse carries a point mutation in a myelin gene. Nature 356, 241-244.
76. Giese, K. P., Martini, R., Lemke, G., Soriano, P. and Schachner, M. (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565-576.
77. Wrabetz, L., Feltri, M. L., Quattrini, A., Imperiale, D., Previtali, S., D'Antonio, M., et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148, 1021-1034.
78. Wrabetz, L., D'Antonio, M., Pennuto, M., Dati, G., Tinelli, E., Fratta, P., et al. (2006) Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 26, 2358-2368. (Pubitemid 44699045)
79. Le, N., Nagarajan, R., Wang, J. Y., Araki, T., Schmidt, R. E. and Milbrandt, J. (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 102, 2596-2601. (Pubitemid 40279422)
80. Topilko, P., Schneider-Maunoury, S., Levi, G., Baron-Van Evercooren, A., Chennoufi, A. B., Seitanidou, T., et al. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799. (Pubitemid 24333867)
81. Nelles, E., Butzler, C., Jung, D., Temme, A., Gabriel, H. D., Dahl, U., et al. (1996) Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 93, 9565-9570. (Pubitemid 26296648)
82. Anzini, P., Neuberg, D. H., Schachner, M., Nelles, E., Willecke, K., Zielasek, J., et al. (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 17, 4545-4551. (Pubitemid 27246912)
83. Jeng, L. J., Balice-Gordon, R. J., Messing, A., Fischbeck, K. H. and Scherer, S. S. (2006) The effects of a dominant connexin 32 mutant in myelinating Schwann cells. Mol Cell Neurosci 32, 283-298. (Pubitemid 44026520)
84. Detmer, S. A., Vande Velde, C., Cleveland, D.W. and Chan, D. C. (2008) Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet 17, 367-375.
85. Lee, M. K., Marszalek, J. R. and Cleveland, D. W. (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13, 975-988. (Pubitemid 24347310)
86. Zhu, Q., Couillard-Despres, S. and Julien, J. P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148, 299-316. (Pubitemid 127445138)
87. Huang, L., Min, J. N., Masters, S., Mivechi, N. F. and Moskophidis, D. (2007) Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis 45, 487-501. (Pubitemid 47584207)
88. Gillespie, C. S., Sherman, D. L., Fleetwood-Walker, S. M., Cottrell, D. F., Tait, S., Garry, E. M., et al. (2000) Peripheral demyelination and neuropathic pain behavior in periaxindeficient mice. Neuron 26, 523-531.
89. Brandon, E. P., Lin, W., D'Amour, K. A., Pizzo, D. P., Dominguez, B., Sugiura, Y., et al. (2003) Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 23, 539-549. (Pubitemid 36139553)
90. Misgeld, T., Burgess, R. W., Lewis, R. M., Cunningham, J. M., Lichtman, J. W. and Sanes, J. R. (2002) Roles of neurotransmitter in synapse formation. Development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36, 635-648. (Pubitemid 35346757)
91. Buffelli, M., Burgess, R. W., Feng, G., Lobe, C. G., Lichtman, J. W. and Sanes, J. R. (2003) Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition. Nature 424, 430-434. (Pubitemid 36917491)
92. Prado, V. F., Martins-Silva, C., de Castro, B. M., Lima, R. F., Barros, D. M., Amaral, E., et al. (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51, 601-612. (Pubitemid 44314080)
93. Feng, G., Krejci, E., Molgo, J., Cunningham, J. M., Massoulie, J. and Sanes, J. R. (1999) Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol 144, 1349-1360. (Pubitemid 29157310)
94. Adler, M., Manley, H. A., Purcell, A. L., Deshpande, S. S., Hamilton, T. A., Kan, R. K., et al. (2004) Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve 30, 317-327. (Pubitemid 39108997)
95. Mesulam, M. M., Guillozet, A., Shaw, P., Levey, A., Duysen, E. G. and Lockridge, O. (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110, 627-639. (Pubitemid 34270534)
96. Burgess, R. W., Nguyen, Q. T., Son, Y. J., Lichtman, J. W. and Sanes, J. R. (1999) Alternatively spliced isoforms of nerve-and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 23, 33-44. (Pubitemid 29262462)
97. Burgess, R. W., Skarnes, W. C. and Sanes, J. R. (2000) Agrin isoforms with distinct amino termini: differential expression, localization, and function. J Cell Biol 151, 41-52.
98. Lin, W., Burgess, R. W., Dominguez, B., Pfaff, S. L., Sanes, J. R. and Lee, K. F. (2001) Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410, 1057-1064. (Pubitemid 32391032)
99. Harvey, S. J., Jarad, G., Cunningham, J., Rops, A. L., van der Vlag, J., Berden, J. H., et al. (2007) Disruption of glomerular basement membrane charge through podocytespecific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 171, 139-152. (Pubitemid 47339234)
100. Gautam, M., Noakes, P. G., Moscoso, L., Rupp, F., Scheller, R. H., Merlie, J. P., et al. (1996) Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85, 525-535. (Pubitemid 26157191)
101. DeChiara, T. M., Bowen, D. C., Valenzuela, D. M., Simmons, M. V., Poueymirou, W. T., Thomas, S., et al. (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85, 501-512. (Pubitemid 26157189)
102. Weatherbee, S. D., Anderson, K. V. and Niswander, L. A. (2006) LDL-receptorrelated protein 4 is crucial for formation of the neuromuscular junction. Development 133, 4993-5000. (Pubitemid 46085064)
103. Gautam, M., Noakes, P. G., Mudd, J., Nichol, M., Chu, G. C., Sanes, J. R.,et al. (1995) Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377, 232-236.
104. Okada, K., Inoue, A., Okada, M., Murata, Y., Kakuta, S., Jigami, T., et al. (2006) The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312, 1802-1805. (Pubitemid 43962899)
105. Noakes, P. G., Gautam, M., Mudd, J., Sanes, J. R. and Merlie, J. P. (1995) Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin beta 2. Nature 374, 258-262.
106. Friese, M. B., Blagden, C. S. and Burden, S. J. (2007) Synaptic differentiation is defective in mice lacking acetylcholine receptor betasubunit tyrosine phosphorylation. Development 134, 4167-4176.
107. Missias, A. C., Mudd, J., Cunningham, J. M., Steinbach, J. H., Merlie, J. P. and Sanes, J. R. (1997) Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit. Development 124, 5075-5086. (Pubitemid 28025131)
108. Witzemann, V., Schwarz, H., Koenen, M., Berberich, C., Villarroel, A., Wernig, A., et al. (1996) Acetylcholine receptor epsilonsubunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc Natl Acad Sci USA 93, 13286-13291. (Pubitemid 26382808)
109. Takahashi, M., Kubo, T., Mizoguchi, A., Carlson, C. G., Endo, K. and Ohnishi, K. (2002) Spontaneous muscle action potentials fail to develop without fetal-type acetylcholine receptors. EMBO Rep 3, 674-681.
110. Koenen, M., Peter, C., Villarroel, A., Witzemann, V. and Sakmann, B. (2005) Acetylcholine receptor channel subtype directs the innervation pattern of skeletal muscle. EMBO Rep 6, 570-576. (Pubitemid 40973967)
111. Liu, Y., Padgett, D., Takahashi, M., Li, H., Sayeed, A., Teichert, R. W., et al. (2008) Essential roles of the acetylcholine receptor gamma-subunit in neuromuscular synaptic patterning. Development 135, 1957-1967. (Pubitemid 351943360)
112. Sicinski, P., Geng, Y., Ryder Cook, A. S., Barnard, E. A., Darlison, M. G. and Barnard, P. J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580. (Pubitemid 19189735)
113. Chapman, V. M., Miller, D. R., Armstrong, D. and Caskey, C. T. (1989) Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USAm 86, 1292-1296. (Pubitemid 19061532)
114. Danko, I., Chapman, V. and Wolff, J. A. (1992) The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res 32, 128-131.
115. Cox, G. A., Phelps, S. F., Chapman, V. M. and Chamberlain, J. S. (1993) New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nature Genetics 4, 87-93. (Pubitemid 23165920)
116. Im, W. B., Phelps, S. F., Copen, E. H., Adams, E. G., Slightom, J. L. and Chamberlain, J. S. (1996) Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet 5, 1149-1153. (Pubitemid 26318554)
117. Araki, E., Nakamura, K., Nakao, K., Kameya, S., Kobayashi, O., Nonaka, I., et al. (1997) Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Biochem Biophys Res Commun 238, 492-497. (Pubitemid 27464414)
118. Kudoh, H., Ikeda, H., Kakitani, M., Ueda, A.,Hayasaka, M., Tomizuka, K., et al. (2005) A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Biochem Biophys Res Commun 328, 507-516. (Pubitemid 40208339)
119. Grewal, P. K., Holzfeind, P. J., Bittner, R. E. and Hewitt, J. E. (2001) Mutant glycosyltransferase and altered glycosylation of alphadystroglycan in the myodystrophy mouse. Nat Genet 28, 151-154. (Pubitemid 32538060)
120. Lee, Y., Kameya, S., Cox, G. A., Hsu, J., Hicks, W., Maddatu, T. P., et al. (2005) Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases.Mol Cell Neurosci 30, 160-172. (Pubitemid 41316560)
121. Kuang, W., Xu, H., Vachon, P. H., Liu, L., Loechel, F., Wewer, U. M., et al. (1998) Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest 102, 844-852. (Pubitemid 28399618)
122. Michelson, A. M., Russell, E. S. and Harman, P. J. (1955) Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 12, 1079-1084.
123. Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K., et al. (1997) Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415, 33-39. (Pubitemid 27402044)
124. Patton, B. L., Wang, B., Tarumi, Y. S., Seburn, K. L. and Burgess, R. W. (2008) A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. J Cell Sci 121, 1593-1604. (Pubitemid 351911816)
125. Sunada, Y., Bernier, S. M., Utani, A., Yamada, Y. and Campbell, K. P. (1995) Identification of a novel mutant transcript of laminin a2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet 4, 1055-1061.
126. Bittner, R. E., Anderson, L. V., Burkhardt, E., Bashir, R., Vafiadaki, E., Ivanova, S., et al. (1999) Dysferlin deletion in SJL mice (SJLDysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 23, 141-142. (Pubitemid 29455382)
127. Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C. C., Williamson, R., et al. (2003) Defective membrane repair in dysferlindeficient muscular dystrophy. Nature 423, 168-172. (Pubitemid 36569539)
128. Ho, M., Post, C. M., Donahue, L. R., Lidov, H. G., Bronson, R. T., Goolsby, H., et al. (2004) Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 13, 1999-2010. (Pubitemid 39377824)
129. Grady, R. M., Grange, R. W., Lau, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T., et al. (1999) Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1, 215-220. (Pubitemid 129500940)
130. Bonaldo, P., Braghetta, P., Zanetti, M., Piccolo, S., Volpin, D. and Bressan, G. M. (1998) Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet 7, 2135-2140. (Pubitemid 28546424)
131. Irwin, W. A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., et al. (2003) Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 35, 367-371. (Pubitemid 37486921)
132. Eklund, L., Piuhola, J., Komulainen, J., Sormunen, R., Ongvarrasopone, C., Fassler, R., et al. (2001) Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci USA 98, 1194-1199. (Pubitemid 32121209)
133. Galbiati, F., Engelman, J. A., Volonte, D., Zhang, X. L., Minetti, C., Li, M., et al. (2001) Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 276, 21425-21433.
134. Crawford, K., Flick, R., Close, L., Shelly, D., Paul, R., Bove, K., et al. (2002) Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period. Mol Cell Biol 22, 5887-5896. (Pubitemid 34815837)
135. Ilkovski, B., Cooper, S. T., Nowak, K., Ryan, M. M., Yang, N., Schnell, C., et al. (2001) Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 68, 1333-1343. (Pubitemid 32510609)
136. Garvey, S. M., Rajan, C., Lerner, A. P., Frankel, W. N. and Cox, G. A. (2002) The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal musclespecific domain of titin. Genomics 79, 146-149. (Pubitemid 34124016)
137. Gotthardt, M., Hammer, R. E., Hubner, N., Monti, J., Witt, C. C., McNabb, M., et al. (2003) Conditional expression of mutant Mline titins results in cardiomyopathy with altered sarcomere structure. J Biol Chem 278, 6059-6065. (Pubitemid 36800857)
138. May, S. R., Stewart, N. J., Chang, W. and Peterson, A. S. (2004) A Titin mutation defines roles for circulation in endothelial morphogenesis. Dev Biol 270, 31-46. (Pubitemid 38596927)
139. Brady, J. P., Garland, D. L., Green, D. E., Tamm, E. R., Giblin, F. J. and Wawrousek, E. F. (2001) AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach. Invest Ophthalmol Vis Sci 42, 2924-2934. (Pubitemid 33035292)
140. Homma, S., Iwasaki, M., Shelton, G. D., Engvall, E., Reed, J. C. and Takayama, S. (2006) BAG3 deficiency results in fulminant myopathy and early lethality. Am J Pathol 169, 761-773. (Pubitemid 44411944)
141. Selcen, D., Muntoni, F., Burton, B. K., Pegoraro, E., Sewry, C., Bite, A. V., et al. (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65, 83-89.
142. Li, Z., Colucci-Guyon, E., Pincon-Raymond, M., Mericskay, M., Pournin, S., Paulin, D., et al. (1996) Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol 175, 362-366. (Pubitemid 26160764)
143. Milner, D. J., Weitzer, G., Tran, D., Bradley, A. and Capetanaki, Y. (1996) Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134, 1255-1270. (Pubitemid 26300170)
144. Thornell, L., Carlsson, L., Li, Z., Mericskay, M. and Paulin, D. (1997) Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol 29, 2107-2124. (Pubitemid 27348522)
145. Moza, M., Mologni, L., Trokovic, R., Faulkner, G., Partanen, J. and Carpen, O. (2007) Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice. Mol Cell Biol 27, 244-252. (Pubitemid 46013248)
146. Garvey, S. M., Miller, S. E., Claflin, D. R., Faulkner, J. A. and Hauser, M. A. (2006) Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM. Hum Mol Genet 15, 2348-2362. (Pubitemid 44288680)
147. Sher, R. B., Aoyama, C., Huebsch, K. A., Ji, S., Kerner, J., Yang, Y., et al. (2006) A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem 281, 4938-4948. (Pubitemid 43847756)
148. Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J. F., et al. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci USA 99, 15060-15065. (Pubitemid 35334609)
149. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., et al. (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147, 913-920.
150. Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacene, E., et al. (2005) Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 14, 155-169. (Pubitemid 40123471)
151. Diaz, F., Thomas, C. K., Garcia, S., Hernandez, D. and Moraes, C. T. (2005) Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum Mol Genet 14, 2737-2748. (Pubitemid 41300646)
152. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., et al. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1773.
153. Seznec, H., Agbulut, O., Sergeant, N., Savouret, C., Ghestem, A., Tabti, N., et al. (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10, 2717-2726. (Pubitemid 33133413)
154. Orengo, J. P., Chambon, P., Metzger, D., Mosier, D. R., Snipes, G. J. and Cooper, T. A. (2008) Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci USA 105, 2646-2651. (Pubitemid 351520567)
155. Reddy, S., Smith, D. B., Rich, M. M., Leferovich, J. M., Reilly, P., Davis, B. M., et al. (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 13, 325-335. (Pubitemid 26230499)
156. Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., et al. (2003) A muscleblind knockout model for myotonic dystrophy. Science 302, 1978-1980. (Pubitemid 37523508)
157. Malicdan, M. C., Noguchi, S., Nonaka, I., Hayashi, Y. K. and Nishino, I. (2007) A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 16, 2669-2682. (Pubitemid 350018509)
158. Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23, 99-103. (Pubitemid 29418797)
159. Yang, X., Arber, S., William, C., Li, L., Tanabe, Y., Jessell, T. M., et al. (2001) Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 30, 399-410. (Pubitemid 32530584)
160. Arber, S., Han, B., Mendelsohn, M., Smith, M., Jessell, T. M. and Sockanathan, S. (1999) Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23, 659-674. (Pubitemid 29411557)
161. Schwander, M., Leu, M., Stumm, M., Dorchies, O. M., Ruegg, U. T., Schittny, J., et al. (2003) Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell 4, 673-685. (Pubitemid 36564898)
162. Bruning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Horsch, D., Accili, D., et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559-569. (Pubitemid 128379082)
163. Tallquist, M. D., Weismann, K. E., Hellstrom, M. and Soriano, P. (2000) Early myotome specification regulates PDGFA expression and axial skeleton development. Development 127, 5059-5070. (Pubitemid 32000664)
164. Feltri, M. L., D'Antonio, M., Previtali, S., Fasolini, M., Messing, A. and Wrabetz, L. (1999) P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883, 116-123. (Pubitemid 129495421)
165. Young, P., Qiu, L., Wang, D., Zhao, S., Gross, J. and Feng, G. (2008) Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nat Neurosci 11, 721-728. (Pubitemid 351748115)
166. Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41-51.
167. Misgeld, T., Kerschensteiner, M., Bareyre, F. M., Burgess, R. W. and Lichtman, J. W. (2007) Imaging axonal transport of mitochondria in vivo. Nat Methods 4, 559-561. (Pubitemid 47214773)
168. Zuo, Y., Lubischer, J. L., Kang, H., Tian, L., Mikesh, M., Marks, A., et al. (2004) Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J Neurosci 24, 10999-11009. (Pubitemid 40012958)
169. Wichterle, H., Lieberam, I., Porter, J. A. and Jessell, T. M. (2002) Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397.
170. Livet, J., Weissman, T. A., Kang, H., Draft, R. W., Lu, J., Bennis, R. A., et al. (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450, 56-62. (Pubitemid 350070576)
171. Coleman, M. P., Conforti, L., Buckmaster, E. A., Tarlton, A., Ewing, R. M., Brown, M. C., et al. (1998) An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci USA 95, 9985-9990.